ALFA Finder| Revenue growth | 15.66% YoY for FY26. |
|---|---|
| Margins | EBITDA margin softened to 8.56% in FY26 vs 10.64% in FY25. |
| Demand visibility | Strong volume growth in regulated markets. |
| Management confidence | High, citing strong regulatory compliance and capacity enhancements. |
Growth
FY26 Revenue rose 15.7% to ₹776 Cr; EBITDA grew 6.5% to ₹67.84 Cr; Total Production up 25% to 1733 MT.
Outlook
Capacity expanded to 2400 MTPA; focus on niche APIs, process innovation, and increasing export share in regulated markets.
Risks
Global market challenges impacted Q4 profitability; currency risks mentioned regarding export dependency.
Earnings Call filed with BSE, NSE: ANUHPHR. Summary written with AI assistance from the document.
Anuh Pharma Ltd: key numbers
- Share price
- ₹83.30
- Market cap
- ₹834.9 Cr
- Revenue (annual)
- ₹771.7 Cr
- Net profit (annual)
- ₹41.05 Cr
- P/E (TTM)
- 17.5×Sector 43.8×
- Promoter holding
- 71.80%+0.00% QoQ
- FII holding
- 0.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anuh Pharma Ltd
All →Anuh Pharma Promoter Reclassification
Anuh Pharma's promoter group member Nina Vijay Shah withdrew her request to reclassify to the public category. She remains in the promoter group.
Anuh Pharma Q2 FY27 Results: Net Profit ₹11.2 Cr, Up 47.4% YoY
Anuh Pharma Ltd reported revenue from operations of ₹185.2 Cr (-0.4% YoY) and net profit of ₹11.2 Cr (+47.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹11.2 Cr · +47.4% YoY
Anuh Pharma Board Meeting Date
Anuh Pharma's board meets on 30 October 2026 to approve Q1/H1 FY27 results. Trading window closed for insiders until 1 November 2026.
Anuh Pharma Acquisition Worth ₹72.9 Cr
Anuh Pharma signed an Asset Transfer Agreement to acquire a manufacturing facility from Vanquest Pharma for ₹72.90 Crore, increasing its production capacity by 525 MTPA.
- Value
- ₹72.90 Cr
- manufacturing capacity
- 525.0 MTPA
Anuh Pharma Debt & Borrowing: ₹75 Cr
Anuh Pharma Ltd board approved a loan of ₹75 Crore to finance manufacturing asset investments for expanding production capacity.
- Value
- ₹75.00 Cr
Anuh Pharma Other Announcement
Anuh Pharma Ltd filed the quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, as issued by its RTA.